Lista de obras - S Allen - Dominio Público Uruguay

A Phase I dose-finding study using an innovative sequential biweekly schedule of irinotecan followed 24 hours later by capecitabine

artículo científico publicado en 2007

A phase II trial of didemnin B in myeloma. A Cancer and Leukemia Group B (CALGB) study

scientific article published on 01 January 1994

A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.

artículo científico publicado en 2015

Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone.

artículo científico publicado en 2003

Acute basophilic leukemia associated with loss of gene ETV6 and protean complications

artículo científico publicado en 2011

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

artículo científico publicado en 2014

Aggressive phase multiple myeloma: a terminal anaplastic transformation resembling high-grade lymphoma

artículo científico

Amonafide: a potential role in treating acute myeloid leukemia

artículo científico publicado en 2011

An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B

artículo científico publicado en 1998

Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus

artículo científico publicado en 2014

Assessment of risk evaluation and mitigation strategies in oncology: summary of the oncology risk evaluation and mitigation strategies workshop

artículo científico publicado en 2013

B-cell precursor acute lymphoblastic leukemia with isolated t(14;19)(q32;q13) abnormality involving the CEBPG gene.

artículo científico publicado en 2015

Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab

artículo científico publicado en 2012

Can leukemia be treated without breaking the bank? ⬇️

artículo científico publicado el 3 de enero de 2013

Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells

artículo científico publicado en 2009

Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification.

artículo científico publicado en 2002

Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.

artículo científico publicado en 2008

Clofarabine-induced kidney toxicity.

artículo científico

Clostridium sordellii bacteremia: case report and review

artículo científico publicado el 1 de diciembre de 1992

Concepts related to salt resistant estradiol receptors in rat uterine nuclei: nuclear matrix

artículo científico publicado en 1977

Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability.

artículo científico publicado en 2015

Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status.

artículo científico publicado en 2004

Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Gr

artículo científico publicado en 2004

Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.

artículo científico publicado en 2004

First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.

artículo científico publicado en 2011

Heparin-induced thrombocytopenia complicating hemodialysis.

artículo científico publicado en 2007

IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions

artículo científico publicado en 2012

IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria

artículo científico publicado en 2014

Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes

artículo científico publicado en 2015

IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing

artículo científico publicado en 1994

In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia.

artículo científico publicado en 2008

Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells ⬇️

artículo científico publicado el 23 de septiembre de 2011

Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature.

artículo científico publicado en 2010

Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A ⬇️

artículo científico publicado el 16 de diciembre de 2011

Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins

scientific article published on 15 April 2019

Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion

scientific article published on 01 August 2018

Monosomy 5 in acute megakaryoblastic leukemia. Report of two cases

artículo científico publicado en 1988

Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia

artículo científico publicado en 2004

Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors

artículo científico publicado en 1987

Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA)

artículo científico publicado en 2008

Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparin

artículo científico publicado en 2010

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

artículo científico publicado en 2011

Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing schedule

artículo científico publicado en 1990

Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma

artículo científico publicado en 1991

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule

artículo científico publicado en 1991

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma

artículo científico publicado en 2009

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia

artículo científico publicado en 2015

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

artículo científico publicado en 2003

Phosphorylation of nuclear matrix proteins in isolated regenerating rat liver nuclei

artículo científico publicado en 1977

Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia

Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data

artículo científico publicado en 2015

Sequential development of two separate therapy-related myeloid neoplasms following radiotherapy for prostate cancer

artículo científico publicado en 2016

Serial cytogenetic alterations resulting in transformation of a low-grade follicular lymphoma to Burkitt lymphoma

artículo científico publicado en 2006

Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia.

artículo científico publicado en 2006

Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia.

artículo científico publicado en 2015

Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphoma.

artículo científico publicado en 2010

Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis.

artículo científico publicado en 2015

T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.

artículo científico publicado en 2012

TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells

artículo científico publicado en 2015

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations ⬇️

artículo científico publicado el 22 de septiembre de 2003

Terminal-phase chronic myelogenous leukemia: approaches to treatment.

artículo científico publicado en 1985

Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance ⬇️

artículo científico publicado el 4 de noviembre de 2011

The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemia

artículo científico publicado en 1988

Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin

artículo científico publicado en 1993

Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera.

artículo científico publicado en 2011

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

artículo científico publicado en 1995

Treatment of aggressive non-Hodgkin's lymphoma in elderly patients with thiotepa, Novantrone (mitoxantrone), vincristine, prednisone (TNOP).

artículo científico publicado en 2001

Lista de obras de S Allen

A Phase I dose-finding study using an innovative sequential biweekly schedule of irinotecan followed 24 hours later by capecitabine

A phase II trial of didemnin B in myeloma. A Cancer and Leukemia Group B (CALGB) study

A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.

Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone.

Acute basophilic leukemia associated with loss of gene ETV6 and protean complications

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

Aggressive phase multiple myeloma: a terminal anaplastic transformation resembling high-grade lymphoma

Amonafide: a potential role in treating acute myeloid leukemia

An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B

Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus

Assessment of risk evaluation and mitigation strategies in oncology: summary of the oncology risk evaluation and mitigation strategies workshop

B-cell precursor acute lymphoblastic leukemia with isolated t(14;19)(q32;q13) abnormality involving the CEBPG gene.

Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab

Can leukemia be treated without breaking the bank? ⬇️

Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells

Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification.

Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.

Clofarabine-induced kidney toxicity.

Clostridium sordellii bacteremia: case report and review

Concepts related to salt resistant estradiol receptors in rat uterine nuclei: nuclear matrix

Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability.

Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status.

Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Gr

Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.

First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.

Heparin-induced thrombocytopenia complicating hemodialysis.

IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions

IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria

Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes

IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing

In-vitro synergism of m-TOR inhibitors, statins, and classical chemotherapy: potential implications in acute leukemia.

Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells ⬇️

Management of acute anemia in a Jehovah's Witness patient with acute lymphoblastic leukemia with polymerized bovine hemoglobin-based oxygen carrier: a case report and review of literature.

Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A ⬇️

Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins

Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion

Monosomy 5 in acute megakaryoblastic leukemia. Report of two cases

Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia

Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors

Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA)

Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparin

Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma

Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing schedule

Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia

Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.

Phosphorylation of nuclear matrix proteins in isolated regenerating rat liver nuclei

Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia

Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data

Sequential development of two separate therapy-related myeloid neoplasms following radiotherapy for prostate cancer

Serial cytogenetic alterations resulting in transformation of a low-grade follicular lymphoma to Burkitt lymphoma

Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemia.

Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia.

Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphoma.

Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis.

T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.

TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations ⬇️

Terminal-phase chronic myelogenous leukemia: approaches to treatment.

Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevance ⬇️

The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemia

Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin

Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera.

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

Treatment of aggressive non-Hodgkin's lymphoma in elderly patients with thiotepa, Novantrone (mitoxantrone), vincristine, prednisone (TNOP).